Amdocs (DOX) to Release Earnings on Wednesday

Key Points

• Amdocs (NASDAQ: DOX) is expected to announce its Q3 2025 earnings on August 6th, with analysts predicting earnings of $1.71 per share and revenue of $1.13 billion.
• The company reported a 9.4% year-over-year decline in revenue last quarter, alongside a net margin of 11.39% and a return on equity of 19.52%.
• Amdocs recently declared a quarterly dividend of $0.527, resulting in an annualized dividend of $2.11 and a yield of 2.43%.

Amdocs (NASDAQ:DOX - Get Free Report) is projected to announce its Q3 2025 earnings results after the market closes on Wednesday, August 6th. Analysts expect the company to announce earnings of $1.71 per share and revenue of $1.13 billion for the quarter. Amdocs has set its FY 2025 guidance at 6.860-7.120 EPS and its Q3 2025 guidance at 1.680-1.740 EPS.

Amdocs (NASDAQ:DOX - Get Free Report) last posted its quarterly earnings data on Wednesday, May 7th. The technology company reported $1.78 earnings per share (EPS) for the quarter, topping the consensus estimate of $1.71 by $0.07. Amdocs had a return on equity of 19.52% and a net margin of 11.39%. The company had revenue of $1.13 billion for the quarter, compared to analysts' expectations of $1.12 billion. During the same period in the previous year, the firm posted $1.56 EPS. Amdocs's revenue was down 9.4% compared to the same quarter last year. On average, analysts expect Amdocs to post $6 EPS for the current fiscal year and $7 EPS for the next fiscal year.

Amdocs Price Performance

DOX stock traded down $0.87 during trading on Friday, hitting $84.49. The stock had a trading volume of 1,027,433 shares, compared to its average volume of 716,105. The company has a debt-to-equity ratio of 0.21, a current ratio of 1.16 and a quick ratio of 1.16. Amdocs has a twelve month low of $78.61 and a twelve month high of $95.41. The stock has a market capitalization of $9.54 billion, a P/E ratio of 17.79, a PEG ratio of 1.40 and a beta of 0.51. The company's 50-day moving average price is $90.67 and its two-hundred day moving average price is $88.68.

Amdocs Dividend Announcement

The company also recently disclosed a quarterly dividend, which was paid on Friday, July 25th. Investors of record on Monday, June 30th were issued a $0.527 dividend. This represents a $2.11 annualized dividend and a yield of 2.5%. The ex-dividend date was Monday, June 30th. Amdocs's payout ratio is presently 44.42%.

Institutional Inflows and Outflows

Institutional investors have recently bought and sold shares of the business. Amundi increased its holdings in Amdocs by 73.0% in the 1st quarter. Amundi now owns 13,778 shares of the technology company's stock valued at $1,217,000 after purchasing an additional 5,816 shares during the last quarter. Millennium Management LLC increased its holdings in Amdocs by 458.3% in the 1st quarter. Millennium Management LLC now owns 67,047 shares of the technology company's stock valued at $6,135,000 after purchasing an additional 55,038 shares during the last quarter. Goldman Sachs Group Inc. increased its holdings in Amdocs by 12.6% in the 1st quarter. Goldman Sachs Group Inc. now owns 331,146 shares of the technology company's stock valued at $30,300,000 after purchasing an additional 37,087 shares during the last quarter. Empowered Funds LLC increased its holdings in Amdocs by 12.0% in the 1st quarter. Empowered Funds LLC now owns 15,979 shares of the technology company's stock valued at $1,462,000 after purchasing an additional 1,709 shares during the last quarter. Finally, Jane Street Group LLC increased its holdings in Amdocs by 195.4% in the 1st quarter. Jane Street Group LLC now owns 115,929 shares of the technology company's stock valued at $10,608,000 after purchasing an additional 76,683 shares during the last quarter. 92.02% of the stock is owned by hedge funds and other institutional investors.

Wall Street Analysts Forecast Growth

DOX has been the topic of several research analyst reports. Wolfe Research assumed coverage on Amdocs in a report on Tuesday, July 8th. They issued an "outperform" rating on the stock. Wall Street Zen lowered shares of Amdocs from a "buy" rating to a "hold" rating in a research note on Saturday. One analyst has rated the stock with a hold rating and four have assigned a buy rating to the stock. According to data from MarketBeat, Amdocs has an average rating of "Moderate Buy" and a consensus price target of $105.33.

Amdocs Company Profile

Amdocs Limited, through its subsidiaries, provides software and services worldwide. It designs, develops, operates, implements, supports, and markets open and modular cloud portfolio. The company provides CES23, a 5G and cloud-native microservices-based market-leading customer experience suite, that enables service providers to build, deliver, and monetize advanced services; Amdocs Subscription Marketplace, a software-as-a-service-based platform that includes an expansive network of pre-integrated digital services, such as media, gaming, eLearning, sports, and retail to security and business services; the monetization suite for charging, billing, policy, and revenue management; Intelligent networking suite with a set of modular, flexible, and open service lifecycle management capabilities for network automation journeys; amAIz, a telco GenAI framework; Amdocs Digital Brands Suite, a pre-integrated digital business suite; and Amdocs eSIM Cloud for service providers.